Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysis
Overview
Optical coherence tomography (OCT) is a non-invasive retinal imaging technology that can provide high-resolution cross-sectional images of the peripapillary retinal nerve fiber layer (RNFL) and measure its thickness. A reduction of the RNFL thickness has been detected in several neurodegenerative diseases, such as multiple sclerosis, CADASIL and Alzheimer's disease. Different studies have reported RNFL changes also in Parkinson's disease (PD),a common neurodegenerative disease characterized by motor dysfunctions, originally described by James Parkinson in 1817. PD is characterized by selective dopaminergic neuronal cells loss, which may correlate with RNFL thinning. Previous studies on this subject, however, reported contradicting results. Some investigations reported reductions of the RNFL thickness while others did not. In the present study, in order to determine whether RNFL thickness is reduced in PD patients, we performed a meta-analysis and systematically evaluated RNFL thickness measurements with OCT in a series of PD patients and in the healthy control groups.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: January 2014
Interventions
- Device: Optical coherence tomography
Arms, Groups and Cohorts
- healthy control
- Sex- and agematched healthy subjects
- Parkinson group
- Patients with Parkinson’s disease
Clinical Trial Outcome Measures
Primary Measures
- Retinal Nerve Fiber Layer Thickness
- Time Frame: Baseline
- Retinal nerve fiber layer thickness included average thickness (360° measurement), temporal quadrant thickness (316-45°), superior quadrant thickness (46-135°), nasal quadrant thickness (136-225°) and inferior quadrant thickness (226-315°)was measured by OCT.
Participating in This Clinical Trial
Inclusion Criteria
1. case-control studies; 2. patients with PD were compared with healthy controls; 3. all subjects underwent RNFL thickness measurement by OCT; 4. studies should provide the data of peripapillary RNFL thickness; 5. sample size ≥10 in each group. Exclusion Criteria:
1. authors did not make RNFL measurements; 2. study without healthy control group; 3. the outcome values can not be used for meta-analysis; 4. duplicated articles.
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 80 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Yifan Feng
- Collaborator
- Wenzhou Medical University
- Provider of Information About this Clinical Study
- Sponsor-Investigator: Yifan Feng, Eye Hospital, Wenzhou Medical College, China – Wenzhou Medical University
- Overall Official(s)
- Yifan Feng, PhD, Principal Investigator, Wenzhou Medical University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.